These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38494822)

  • 1. [A Case of Pathologically Complete Response after Preoperative Chemotherapy in a Locally Advanced Rectal Cancer].
    Kosaka A; Kasahara K; Kuboyama Y; Udo R; Tago T; Mazaki J; Ishizaki T; Nagakawa Y
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):332-333. PubMed ID: 38494822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Perforated Rectal Cancer with Laparoscopic Low Anterior Resection].
    Takashima J; Kobayashi H; Koizumi A; Shigehara F; Yamasaki K; Fujimoto D; Sugimoto H; Miura F; Taniguchi K; Matsutani N
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1915-1917. PubMed ID: 38303251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two Cases of Locally Advanced Lower Rectal Cancer with Pathological Complete Response after Cetuximab plus SOX as Neoadjuvant Chemotherapy].
    Tokuhara K; Satake R; Ueyama Y; Yamamichi K; Sekimoto M
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1405-1407. PubMed ID: 34795136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.
    Naiken SP; Toso C; Rubbia-Brandt L; Thomopoulos T; Roth A; Mentha G; Morel P; Gervaz P
    BMC Surg; 2014 Jan; 14():4. PubMed ID: 24438090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 7. Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review.
    Mori R; Uemura M; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Mizushima T; Doki Y; Eguchi H
    World J Surg Oncol; 2022 May; 20(1):166. PubMed ID: 35619103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy.
    Chang H; Tao YL; Jiang W; Chen C; Liu SL; Ye WJ; Gao YH
    BMC Cancer; 2020 Jun; 20(1):498. PubMed ID: 32487091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
    JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
    Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S;
    BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Conversion Surgery after Chemotherapy for Locally Advanced Unresectable Rectal Cancer].
    Kawabe Y; Inoue A; Kagawa Y; Nishizawa Y; Ozato Y; Hayashi N; Shindo M; Suzuki K; Komatsu H; Hirota M; Miyazaki Y; Tomokuni A; Motoori M; Iwase K; Fujitani K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1768-1770. PubMed ID: 38303201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Robot-Assisted Abdominoperineal Resection Alongside En Bloc Prostatectomy and Vesico-Urethral Anastomosis for Local Recurrence].
    Omori I; Shibutani M; Fukuoka T; Kasashima H; Kitayama K; Miki Y; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Lee S; Kato M; Yamazaki T; Uchida J; Maeda K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1482-1484. PubMed ID: 38303315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
    Mizushima T; Ikeda M; Kato T; Ikeda A; Nishimura J; Hata T; Matsuda C; Satoh T; Mori M; Doki Y
    BMC Cancer; 2019 Sep; 19(1):929. PubMed ID: 31533662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Pathological CR in Local Advanced Rectal Cancer Treated with Laparoscopic ISR after XELOXIRI Chemotherapy].
    Kawai K; Murata K; Hata T; Kagawa Y; Naito A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2096-2097. PubMed ID: 32157071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Robotic-Assisted Total Pelvic Exenteration for Locally Advanced Rectal Cancer Invading the Prostate].
    Tanida T; Ikenaga M; Ueda M; Ko M; Iede K; Tsuda Y; Nakashima S; Matsuyama J; Yamada T
    Gan To Kagaku Ryoho; 2022 Apr; 49(4):453-455. PubMed ID: 35444133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological Complete Response in Multiple Advanced Rectal Cancers with Neoadjuvant CapeOX plus BV Therapy-A Case Report].
    Kuge K; Matsuda A; Fujihira T; Baba Y; Yamada T; Matsumoto S; Suzuki H; Fujihira N; Yoshida H
    Gan To Kagaku Ryoho; 2020 Sep; 47(9):1383-1385. PubMed ID: 33130706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).
    Hattori N; Nakayama G; Uehara K; Aiba T; Ishigure K; Sakamoto E; Tojima Y; Kanda M; Kobayashi D; Tanaka C; Yamada S; Koike M; Fujiwara M; Nagino M; Kodera Y
    Int J Clin Oncol; 2020 Jan; 25(1):118-125. PubMed ID: 31542847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Two Stage taTME for Perforated Rectal Cancer during Chemotherapy].
    Kubota S; Morohashi H; Sakamoto Y; Miura T; Ichinohe D; Watanabe N; Kanda T; Hagiwara Y; Fujita H; Nakamura A; Matsumoto T; Yamazaki K; Yamada T; Yamamoto T; Hakamada K
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1706-1708. PubMed ID: 35046304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.